Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 5.5B | 3.0B | 5.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 55M | 95M | 86M | 19M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 50M | 50M | 50M | 50M |
Other income expense | 25M | 24M | 23M | 22M |
Pretax income | 145M | 2.1B | 92M | 2.0B |
Tax provision | 116M | 233M | 185M | 264M |
Net income | 29M | 1.9B | -93M | 1.8B |
Basic EPS | 0.1 | 3.4 | -0.2 | 3.1 |
Diluted EPS | 0.1 | 3.4 | -0.2 | 3.1 |
Basic average shares | 609.9M | 618.9M | 624.7M | 632.1M |
Diluted average shares | 612.3M | 622.0M | 627.5M | 634.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | 29M | 1.9B | -93M | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |